Ticker
PYXSCompany Name
PYXIS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -98.17M | -3481.1% | $ 2.82M |
3/31/2025 | $ -97.4M | 0% | $ 0 |
12/31/2024 | $ -79.5M | -492.35% | $ 16.15M |
9/30/2024 | $ -57.36M | -355.24% | $ 16.15M |
6/30/2024 | $ -59.2M | -366.67% | $ 16.15M |
3/31/2024 | $ -57.8M | -358% | $ 16.15M |
12/31/2023 | $ -73.79M | 0% | $ 0 |
9/30/2023 | $ -94.29M | 0% | $ 0 |
6/30/2023 | $ -98.92M | 0% | $ 0 |
3/31/2023 | $ -108.58M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for PYXIS ONCOLOGY INC is calculated as follows: EBIT [ $ -12.83M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |